Effect of Thiol-Disulfide Homeostasis and Ischemia-Modified Albumin Levels on IVF Results in Male Factor Infertility
IVF
The Impact of Thiol-Disulfide Homeostasis and Ischemia-Modified Albumin Levels on In Vitro Fertilization Outcomes in Couples With Male Factor Infertility
1 other identifier
observational
122
1 country
1
Brief Summary
Thiol-disulfide Homeostasis (TDH) is essential for physiological functions in the human reproductive system, including antioxidant defense, detoxification, signal transduction, enzymatic regulation, apoptosis, and cellular communication. Ischemia-Modified Albumin (IMA) serves as an indicator of oxidative stress (OS) and is linked to ischemia-reperfusion injury. This study aimed to investigate changes in OS markers, particularly TDH and IMA levels, in couples with male infertility, and to examine the relationship between these markers and in vitro fertilization (IVF) success. Understanding how TDH and IMA levels influence IVF outcomes is crucial for advancing reproductive treatments for couples having diagnosis of infertility.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 13, 2025
CompletedFirst Posted
Study publicly available on registry
June 24, 2025
CompletedJune 24, 2025
April 1, 2023
7 months
June 13, 2025
June 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Live birth rate (LBR)
live births to the total number of embryo transfer cycles
6 months
beta-human chorionic gonadotropin (hCG) positivity
serum ≥ 10 mlU/mL
6 months
clinical pregnancy (CP)
the detection of a gestational sac via transvaginal ultrasonography
6 months
Secondary Outcomes (1)
diagnosing male infertility
6 months
Study Arms (2)
Study Group
undergoing IVF due to male factor infertility
control group
undergoing IVF due to unexplained infertility
Eligibility Criteria
Couples in which women aged 23-45 years and undergoing IVF treatment due to male factor and unexplained infertility were enrolled.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duzce Universitylead
Study Sites (1)
Bilkent City Hospital
Ankara, 06800, Turkey (Türkiye)
Related Publications (3)
Micoogullari U, Cakici MC, Kilic FU, Kisa E, Ozcift B, Caglayan A, Neselioglu S, Karatas OF, Erel O. Evaluation of the role of thiol / disulfide homeostasis in the etiology of idiopathic male infertility with a novel and automated assay. Syst Biol Reprod Med. 2022 Apr;68(2):162-168. doi: 10.1080/19396368.2021.2003481. Epub 2021 Dec 10.
PMID: 34893004BACKGROUNDZec I, Goldstajn MS, Kuna K, Mikus M, Stabile G, Bianco B, Buzzaccarini G, Lagana AS. Oxidative homeostasis in follicular fluid and reproductive outcomes - from bench to bedside. Prz Menopauzalny. 2022 Dec;21(4):276-284. doi: 10.5114/pm.2022.124019. Epub 2022 Dec 30.
PMID: 36704764BACKGROUNDOzdemir AZ, Karli P, Neseli Oglu S. Does thiol/disulfide homeostasis affect the number of metaphase 2 oocyte in the treatment of in vitro fertilization? Future Sci OA. 2020 Jan 14;6(2):FSO452. doi: 10.2144/fsoa-2019-0132.
PMID: 32025332BACKGROUND
Biospecimen
Serum samples were collected from the males on the day of oocyte pick-up. Blood samples were drawn from the antecubital vein and transferred into gel-based biochemistry tubes for the determination of TDH, IMA and other biochemical parameters.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Müzeyyen Gülnur Özakşit, M.D., Professor
Ankara Bilkent City Hospital, IVF Unit
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D., Professor
Study Record Dates
First Submitted
June 13, 2025
First Posted
June 24, 2025
Study Start
April 1, 2023
Primary Completion
October 31, 2023
Study Completion
June 1, 2025
Last Updated
June 24, 2025
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- From the beginning of study up to now.
All of the data including demographic characteristics and laboratory findings.